“What does a CEO actually do? Would regular workers notice if the company didn’t have one?” “Can you explain stock options?” “What the hell is EBITDA?” On WIRED's Tech Support, Precision Neuroscience CEO Michael Mager takes on the Internet’s burning questions about

Precision Neuroscience will be at the 2025 @Neurocritical Care Society conference this month in Montreal, September 18th - 21st. Join us at the Precision booth to learn about the Layer 7 Cortical Interface, the world’s only high-bandwidth and minimally invasive brain-computer

"There's something that my father told me 20 years ago that I forgot, but I really want to remember what he said word for word. Can technology one day be used to stimulate that and then recall those memories?". That was just one of the questions posed by Alex Alex Kantrowitz on the

Heading to the @Neurocritical Care Society conference in Montreal next week? Come visit us at booth 508 to see Precision's Layer 7 in person. Layer 7 is the world’s only minimally invasive, high-bandwidth brain–computer interface (BCI) — designed to create a direct communication

The @Neurocritical Care Society 2025 annual conference kicks off this evening in Montreal! Stop by the opening reception tonight and meet the Precision Neuroscience team in person. Precision Neuroscience is proud to be the first brain-computer interface (BCI) company to join the

Inc. Magazine recently named Precision Neuroscience as one of the best places to work in 2025, and we're hiring! At Precision Neuroscience, we’re building the next generation of brain-computer interfaces — designed to restore independence and transform care for people living with

"A growing roster of BCI trials is one thing. The actual number of patients implanted is another. And on that front, Precision Neuroscience might have a key advantage over the competition." - Sy Mukherjee, Inc.. Magazine. Exciting article in Inc.. Magazine by @The_Sy_Guy: “5

Can brain-computer interfaces (BCIs) one day record our dreams? How do they move a cursor with thought alone? What does it really take to implant a brain chip? These are just some of the internet’s burning questions on BCIs answered by Dr. Benjamin Rapoport, neurosurgeon and

Precision Neuroscience Co-founder Dr. Benjamin Rapoport will be a featured panelist at the upcoming 2025 New York BCI Symposium. He’ll join leading experts in the brain-computer interface field for the session “BCI Trials Today and Tomorrow: Industry Perspectives”, which is

In a world where too many patients are told, “There’s nothing more we can do,” I’m proud to be part of a team working to change that answer. - Jayme Strauss RN,MSN,MBA,SCRN, Precision Neuroscience Chief Clinical Officer. In a recent Healthcare Brew interview, editor Nicole Ortiz

We’re proud to share that Nature Biomedical Engineering has published our foundational scientific report, providing an overview of Precision's system design and capabilities, results from preclinical animal experiments, and our first-in-human data from 2023. This is the first

➡️Live discussion at #NYBCI25! Dr Ashwini Sharan (Medtronic) & Dr Konstantinos Alataris (Precision Neuroscience) explore “Making it to Market: Lessons from the Frontlines," how #BCI developers balance #clinical breakthroughs w/ regulation, reimbursement & business realities. #Neuro

At #NYBCI25: “#BCI Trials Today & Tomorrow” mod @IkeSwetlitz (Bloomberg) w/ Drs Thomas Oxley (Synchron), Rapoport (Precision Neuroscience), Robinson (@MotifNeuro), Solzbacher (Blackrock Neurotech), Michael T. Lawton, MD (BarrowNeurological), Matt Angle (@Paradromics) & Michael Ivan, MD, MBS, FAANS (UM Neurosurgery).

Precision Neuroscience Co-founder’s @Michael_MagerNY and Dr. Benjamin Rapoport were both recent guests on Wall Street Journal “Bold Names”, and Pushkin "What's Your Problem?" podcasts. Topics of discussion focused on the societal and financial costs of BCIs, the widespread

“We stand at the cusp of a massive technology paradigm shift that promises to transform human civilization. Sam Altman and Elon Musk are building rival companies to compete over what will be one of the biggest market opportunities in history. No, we are not talking about

Precision Neuroscience is proud to share that several of our abstracts have been accepted for presentation at the 2025 Congress of Neurological Surgeons (CNS) conference, currently underway in Los Angeles. We’re honored to have the opportunity to share our latest research and

We’re honored to share that Fast Company has named Precision Neuroscience to its Next Big Things in Tech 2025 list — recognizing innovations poised to shape the future. Precision Neuroscience has been featured in the Excellence in Innovation category, spotlighting “5 innovations of